I shall emphasize contentious issues in the treatment of diabetic coma, although most of the disagreements I shall refer to are now dying away. The hot issues of a few years ago have now cooled into a general acceptance of the newer treatment of diabetic ketoacidosis and coma. My message is that treatment of diabetic ketoacidosis with intravenous saline and continuous infusion or repeated intramuscular injections of small amounts of insulin is safe, simple, effective, and should now be the standard treatment. I can see no reason for adhering to older methods.
Prevention ofcoma
Too many patients are allowed to pass into diabetic ketoacidosis because of delay in diagnosis or poor management of diabetes during intercurrent illness. We still see patients, not previously known to be diabetic, who have consulted their general practitioners with symptoms which should have suggested the diagnosis but whose urine was not tested. In an analysis of 27 consecutive coma patients admitted to King's College Hospital Dr R D G Leslie found that 15 were new cases. In 12 of those the urine had never once peen tested, though they had visited their general practitioners on a total of 41 occasions. Not surprisingly the correct diagnosis had been missed in all but one of these cases.
Ifa diabetic has not raised the dose of insulin when an attack of gastroenteritis has upset his diabetic control he has either not been properly taught or, through mental incapacity or (more likely) emotional disturbance, has not made the adjustment which he should know is necessary. Ketoacidosis may come on in hospital because of carelessness in managing a diabetic during or after serious illness or major operation. A continuous low dose insulin infusion is invaluable in these cases.
Treatment
The three mainstays of treatment of diabetic ketoacidosis are insulin, fluid and electrolyte replacement. There is little disagreement about the second and third; there has been much controversy about the first.
Saline infusion in large quantities is needed in all cases. Except in the mildest cases fluids . cannot be given by mouth. The patient is nearly always nauseated and has usually vomited.
Fluid by mouth may appear to be tolerated until after a couple of hours large quantities of brown fluid are vomited and time, water and potassium have been lost. If there is any doubt saline should be givan intravenously. Except in the elderly patient, where unsuspected heart disease may lead to heart failure if replacement is too rapid, saline should be given quicklyone litre at least in the first hour in the adult. These patients are profoundly dehydrated -they are usually 6 litres depletedand osmotic diuresis will continue for several hours so the total requirement is likely to be great. Potassium is almost always needed in cases of severe diabetic ketoacidosis and should be given intravenously. Serum concentration is usually in the normal range on admission and I prefer to delay the start of treatment until the level has fallen to about 4.5 mmols or less. Then we give 13-26 mmols/hour. The total dose required is usually 50-250 mmols. If bicarbonate is given the amount of potassium needed will be greater, perhaps twice as much.
The serum potassium level should always be monitored, especially if bicarbonate is given. A cardiac monitor gives useful, though not entirely reliable, indication of a change in potassium level.
Bicarbonate is seldom needed but it does have a place. In the very acidotic patient with a pH below 7.1, especially if there is no improvement in ketoacidosis after 2 hours of treatment, 50-100 mEq in dilute solution (not 8.4%) should be given.
Insulin
Until about five years ago there were as many insulin regimes as there were diabetic clinics. All manner of treatments were in use. They varied in the dose, route and timing of insulin administration; these regimes were not only varied, they were complicated. The dose of insulin was calculated by various formulas depending on the degree of glycosuria and ketonuria, and the clinical state of the patient. Formulas in which unlike was related to unlike to produce a recipe which the untutored houseman was expected to follow were in common use. At King's College Hospital we followed the precept of R D Lawrence and gave the number of units of soluble insulin which was 10% of the height of the blood glucose in mg/IOO ml-an illogical but simple formula. Others, especially in the USA, used much higher doses and prided themselves on the amount of insulin they gave. The urge to give larger and larger doses sprang I think from a review of early diabetic coma deaths when too little insulin seemed to have been given and from the mistaken belief that if something does you good, twice as much will do you twice as much good.
Low dose insulin regimes
Modern low dose insulin regimes have two sources. The first was the work of Genuth (1973) who found that continuous insulin infusion was effective in raising serum insulin and lowering serum glucose levels and he proposed a 'low' dose regime of 50 units at once followed by 50 units an hour. Even this regime, which we should now regard as using very high doses, was criticized in an editorial (Journal ofthe American Medical Association 1973) because it required 'no more than 100 units an hour' and doubt was expressed whether such doses would be effective in frank coma.
Perhaps a more important source of the modern treatment of diabetic ketoacidosis was the work of Sonksen et al. (1972) , who showed that minute doses of insulin, 2.4 units per hour, produced metabolic effects. This led to the use of small doses (5-10 units) of insulin given by hourly intramuscular injections (Alberti et 01. 1973) and then to continuous intravenous infusion (Page et 01. 1974 , Kidson et 01. 1974 , Semple et 01. 1974 . It seemed remarkable that such minute doses of insulin should be effective and those who would not try them codtinued to regard them as absurd. Those who would, however, soon found that they were effective. Indeed smaller doses than 6 units an hour have been used, for example in children and cases of hyperosmolar non-ketonic coma, and much smaller doses (1 unit/hour) are adequate to maintain euglycaemia. We now regard 30 units/hour as a huge dose -it is needed only in cases where sympathomimetics (e.g. salbutamol) or steroids (e.g. dexamathasone) are used.
Our standard insulin regime is to start without waiting for laboratory results. Insulin is given by a continuous infusion pump. There are several types of pump now available costing about £100-£300. They have a sight or sound signal to show that they are working (the movement of the plunger is too slow to be seen) and the rate can be adjusted. These pumps are also useful for other clinical crises and any general hospital should have several.
Insulin can be added to the saline infusion bag, but the rate is not then independently variable, or it canbe given through a paediatric drip set.
. We start with 6 units an hour ofsoluble insulin. The amount can be doubled if blood glucose response is not satisfactory or reduced when the blood glucose level has fallen to about 10 mmols/l, It is rarely necessary to increase the rate in cases of diabetic ketoacidosis but occasionally it is, especially if there is infection or if the patient has had steroids. With this treatment, as in all cases of diabetic ketoacidosis, clinical and chemical responses must be properly monitored. The simplicity of the treatment does not reduce this need.
In the majority of cases the blood glucose starts to fall promptly and continues to do so at the rate of about 5 mmols/l each hour. When it has fallen to about 10 mmols/l the rate is halved and glucose (6 g/hour) added to the infusion. This regime can be continued until the patient is well enough to eat; he can then be transferred to a twice daily insulin regime.
Intramuscular insulin -10 or 20 units at once, followed by 5-10 units hourly -is also effective. It depends upon injections being given regularly and thus on nursing efficiency but that is only a minor disadvantage since all these cases require intensive nursing care. There is probably little to choose between the continuous insulin infusion and' hourly intramuscular injection, but our experience has been with the intravenous infusion so we are confident in it and can see no disadvantages.
However, it was criticized strongly when it was first introduced, notably by Madison (1976) , and his doubts were shared by others, particularly in the USA. I was never able to understand the burden of their criticisms. The regime works -one has only to treat a few cases to realize that -and it is simple. The fact that close medical and nursing care are essential is no more a criticism of this regime than of any others. Madison suggested a control trial of 400 cases, half treated by this method and half by the older techniques, a proposal which as far as I know has not been taken up, although a smaller control trial has been done (Fisher et al. 1977) which confirmed the efficacy of the low insulin regime.
The failures in treatment of diabetic ketoacidosis, as most experienced clinicians will agree, come from errors in management. Any insulin regime properly managed will probably work. The issue is which regimes are properly managed. For the doctor who sees cases of severe ketoacidosis relatively rarely it is surely an advantage to have a simple regime of treatment which has been shown to be effective. Furthermore, I suspect, but cannot prove, that the risks of hypokalaemia are less with low dose insulin treatment and this m~apply to the rare cases of cerebral oedema.
The crucial test of the acceptability and effectiveness of low dose insulin infusion is to ask those who use it in practice. All our registrars and housemen have been. convinced of its superiority over previous regimes and indeed it is they who have extended the range of its application to other diabetic problems.
In my opinion there can no longer be any serious doubt that low dose regimes, preferably by continuous intravenous infusion, are better than previous treatments. They need care and they are open to error -in two of our cases the pump was switched off by misguided nurses -but so are all treatments in medicine.
A minor matter of controversy has been whether adsorption of insulin to plastic is important and whether it should be prevented by adding human albumin or polygeline (Kraegen et al. 1975 ). If adsorption does occur it is not significant. The fall of blood glucose is the same whether albumin is added or not (Oakley et al. 1976 ).
Conclusions
Modern methods of treatment of diabetic ketoacidosis and coma with continuous insulin infusion are simple, safe and effective and are therefore better than older, more varied and complicated regimes.
For an excellent review of diabetic ketoacidosis, see Alberti & Hockaday (1977) . The term 'hyperosmolar coma' is a colloquialism for 'hyperosmolar hyperglycaemic nonketotic coma', and because it is widely used in everyday parlance, it will be adopted throughout this paper, for brevity and convenience. This syndrome was first brought to general attention as recently as 1957 by Sament & Schwartz, but has subsequently been reported with everincreasing frequency, and is now believed to comprise at least 10-20% of all cases of diabetic coma (Podolsky 1978) . Even this may be an underestimate, since in a recent study of 86 episodes of diabetic coma, 28 (33%) were due to hyperosmolar coma (Keller et al. 1975) , and it is possible that many cases are unrecognized or unreported (Halmos et 01. 1966 , Podolsky 1978 . Both its diagnosis and treatment contain some notable pitfalls for the unwary, which contribute to the high mortality, and although its management is generally similar to that of diabetic ketoacidotic coma, there are several important differences of emphasis, which may influence the outcome of treatment. These differences will be highlighted in this paper. A useful practical definition, based on the full title of the syndrome, is: those cases of diabetic coma in which the plasma osmolality exceeds 350mosm/kg, the blood glucose exceeds 40 mmol/l, and there are no ketones in the urine, usually indicating the absence of ketoacidosis (adapted from Gordon & Kabadi 1976). On a strict basis, there are several flaws in this definition; for example, patients are usually drowsy rather than comatose (Gerich et 01. 1971) and the absence of ketonuria may be due to renal impairment rather than lack of ketoacidosis (British Medical Journal 1965). More significantly, the definition is dependent on whether the osmolality is actually measured by osmometry or is simply calculated from the blood urea, electrolyte and glucose levels, because the measured osmolality is usually higher than the calculated value (Tomkins & Dormandy 1971). The latter also depends on the particular formula used; for example, some authors omit the urea concentration (McCurdy 1970), and others allow for the osmolal coefficient of plasma being less than unity (Loeb 1974). The increasing use of osmometry will lead to more uniform diagnostic criteria, although it will probably augment the number of patients classified as hyperosmolar. . The subdivision of diabetic coma into ketoacidotic and hyperosmolar coma is somewhat artificial since they probably present two ends of a continuous spectrum of clinical presentations (Foster 1974 , Alberti & Hockaday 1977 . Many patients in diabetic coma are both ketoacidotic and hyperosmolar -the two features are not mutually exclusive. However, the classification is validated not only by the different clinical features of the two extremes, but also by their different mortality rates. In most large published series of hyperosmolar coma, this has been between 40 and 60% (Arieff & Carroll 1972 , McCurdy 1970 although in some series it has been lowered to around 20% (Gerich et 01. 1971) . By contrast, the mortality of ketoacidotic coma is 5-15% (Alberti & Hockaday 1977) . Before discussing the management of hyperosmolar coma, some important factors contributing to the high mortality merit special mention.
